Vas Narasimhan earned a big pay hike when he moved to the CEO's suite at No­var­tis

It’s un­like­ly Vas Narasimhan will rank at the top of any 2018 com­pen­sa­tion lists for Big Phar­ma CEOs. But the No­var­tis helms­man is def­i­nite­ly on a whole new pay scale com­pared to what he earned as a drug de­vel­op­ment chief.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER